HSHuaizhang Shi

Huaizhang Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huaizhang Shi has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Shuai Lan

    Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China

    7 shared publications
  • Bowen Sun

    Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China

    6 shared publications
  • Qiaowei Wu

    Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China

    6 shared publications
  • Kaikun Yuan

    Department of Neurosurgery the First Affiliated Hospital of Harbin Medical University Harbin China

    5 shared publications
  • Pei Wu

    Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China

    5 shared publications
  • Shancai Xu

    Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China

    5 shared publications

Latest Publications

  • Safety and efficacy of a coated flow diverter compatible with 0.017 inch microcatheters: prospective multicenter study

    by Simin Wang, Jun Feng, Chuan He, Jingwei Li, Yin Shen, Jing Xu, Bing Fang, Guangsen Cheng, Yu Liu, Huaizhang Shi, et al.

  • Open Access

    Targeted Degradation of STING by a Neutrophil Membrane‐Coated Nanoplatform Suppresses Microglial Pyroptosis After Subarachnoid Hemorrhage

    by Ruotian Zhang, Kaikun Yuan, Haoyu Zou, Hanfeng Qin, Jiale Liu, Jianda Sun, Feifan Zhang, Yuankui Wang, Tong Wang, Jiaxing Dai, et al.

    Subarachnoid hemorrhage (SAH) is a life‐threatening cerebrovascular disease in which neuroinflammation and neuronal death critically contribute to poor outcomes. Here, we identify aberrant STING activation as a key driver of microglial pyroptosis and post‐SAH injury. Transcriptomic and biochemical analyses support a close association between STING signaling and microglial pyroptosis, with MAPK signaling acting as a functionally relevant downstream pathway. Based on this mechanistic insight, we engineered MG1 peptide‐functionalized, neutrophil membrane‐coated STING‐PROTAC nanoparticles (MG1@NM‐Px) to enable blood‐brain barrier penetration, microglia‐targeted delivery, and efficient STING degradation in vivo. This catalytic degradation suppressed the inflammasome‐related activation and GSDME‐associated pyroptotic signaling, reduced pro‐inflammatory cytokine secretion, and prevented neuronal apoptosis. Histopathological examination showed preserved Nissl body integrity, while behavioral testing revealed significant improvements in neurological function. Collectively, this engineered neutrophil membrane‐coated STING‐PROTAC nanoplatform effectively degrades STING, inhibits microglial pyroptosis, and provides robust neuroprotection in SAH. This work establishes a novel biomimetic nanomedicine strategy for SAH therapy and opens new avenues for treating neuroinflammation‐related disorders.


  • Open Access

    Molecular taxonomy and spatial organization define neuronal subtypes in the mouse inferior colliculus

    by Mengting Liu, Qi Hu, Wenhao Feng, Qi Guo, Tianyu Ma, Xiang Li, Qi Meng, Shijia Xu, Jueqi Li, Tianhong Zhang, et al.


  • Open Access

    Microglia Attenuate Neuroinflammation After Subarachnoid Hemorrhage by Modulating Astrocyte Phenotypic Transformation via the RARα/Mafb/Msr1 Pathway

    by Yuxiao Meng, Yuanzhe Dong, Jiang Shao, Qiaowei Wu, Le Huang, Pei Wu, Shuai Lan, Zurong Yao, Huaizhang Shi, Yuchen Li

    Neuroinflammation mediated by microglia-astrocyte interactions significantly contributes to secondary brain injury after subarachnoid hemorrhage (SAH). Retinoic acid receptor alpha (RARα) has emerged as a potential modulator of neuroinflammation. However, its specific mechanisms in the interaction between microglia and astrocytes after SAH are not yet known. This study investigated whether RARα activation might alleviate neuroinflammation post-SAH by regulating microglial-astrocytic crosstalk via the Mafb/Msr1/PI3K-Akt signaling axis. An in vivo SAH model in male Sprague-Dawley rats was established through endovascular perforation. In vitro, a microglia-astrocyte co-culture system was subjected to oxyhemoglobin treatment to mimic SAH conditions. The RARα-specific agonist Am80 was administered to activate RARα signaling. Key molecular markers (Mafb, Msr1, and PI3K/Akt), pro-/anti-inflammatory cytokines, and glial activation phenotypes were evaluated via western blotting and immunofluorescence. Functional recovery was assessed with neurobehavioral tests. Pathway-specific inhibitors were used for mechanistic validation. RARα activation markedly attenuated neuroinflammation, enhanced neurological outcomes in SAH rats, significantly decreased levels of pro-inflammatory factors, and inhibited neuroinflammation mediated by microglia. Mechanistically, Am80 was found to upregulate the transcription factor Mafb and its downstream target Msr1, thereby triggering PI3K/Akt phosphorylation. This cascade inhibited NF-κB-mediated pro-inflammatory cytokine release and enhanced anti-inflammatory factors. Critically, blockade of PI3K/Akt or knockdown of Mafb/Msr1 abolished the anti-inflammatory effects of Am80. In addition, the inflammatory factor receptors TNF-αR and IL6R were demonstrated to be important mediators of microglia and astrocyte interaction. RARα activation mitigates SAH-induced neuroinflammation by modulating microglial-astrocyte interactions through the Mafb/Msr1/PI3K-Akt pathway. Our findings identified RARα as a promising therapeutic target for ameliorating neuroinflammation and improving recovery after SAH.


  • Open Access

    Educational value of remote live-streamed training in endovascular thrombectomy: dose–response and mediation analysis

    by Shujuan Gan, Jinfeng Miao, Zhiting Chen, Yan-Min Wu, Huaizhang Shi, Changming Wen, Ming-Zhu Huang, Jintao Chen, Jianhua Guan, Bingbo Zhuang, et al.

    Background Remote live-streamed training in endovascular thrombectomy (EVT) is a novel educational strategy. This study evaluated the dose–response relationship between training duration and clinical outcomes, and explored mediation pathways. Methods In a prospective cohort study, 1046 participants received remote EVT training, with 1010 completing follow-up. Locally Estimated Scatterplot Smoothing (LOESS) and segmented regression identified training thresholds. Participants were categorized into low (70 hours) training groups. Inverse probability of treatment weighting (IPTW) was adjusted for baseline differences. Mediation analysis examined the mechanisms of effect. Results A dose–response relationship was evident: outcome improvements accelerated after 25 hours and plateaued beyond 70 hours. After IPTW, patients treated by both medium and high training groups achieved significantly better 90-day outcomes compared with the low training group (medium vs low, adjusted β=1.54, 95% CI 0.94 to 2.15; high vs low, β=3.16, 95% CI 2.28 to 4.04, both PConclusion Remote live-streamed EVT training is significantly associated with improved 90-day functional outcomes. The greatest benefits were observed after 25 hours of training and diminishing returns beyond 70 hours. These gains are partly mediated by enhanced professional competency and improved recanalization outcomes, highlighting the importance of structured, high-quality remote training programs for optimizing neurointerventional care.


  • Open Access

    Direct mechanical thrombectomy vs. intravenous alteplase plus mechanical thrombectomy in acute ischemic stroke with anterior circulation tandem occlusions

    by Zhonghui Yang, Guang Zhang, Qiaowei Wu, Yujing Zhu, Shancai Xu, Huaizhang Shi

    Background and purpose: Tandem occlusion is a significant risk factor for poor outcomes following intravenous thrombolysis. The necessity of bridging therapy [intravenous thrombolysis prior to mechanical thrombectomy (MT)] for patients with tandem occlusion remains controversial. This study assessed the safety and efficacy of direct MT vs. bridging therapy in patients with tandem occlusions in the anterior circulation.Methods: This retrospective study enrolled patients with anterior circulation tandem occlusions treated with either direct mechanical thrombectomy (MT-alone group) or intravenous alteplase thrombolysis followed by MT (bridging group) between January 2019 and March 2022. The primary outcome was prespecified as a favorable outcome [modified Rankin Scale (mRS) score of 0–2] at 90 days. Secondary outcomes included successful reperfusion, overall mortality at 90 days, and rates of symptomatic intracranial hemorrhage (SICH) and asymptomatic intracranial hemorrhage (aSICH).Results: A total of 110 patients were enrolled, with 49 in the MT-alone group and 61 in the bridging group. A favorable outcome (mRS score of 0–2) at 90 days was achieved in 25 patients (51.0%) in the MT-alone group and in 34 patients (55.7%) in the bridging group, showing no significant difference between the groups, with an adjusted odds ratio (aOR) of 1.17 (95% CI, 0.47–2.90; P = 0.743). The incidence of aSICH was higher in the bridging group than in the MT-alone group [31.1% vs. 14.3%; aOR, 2.86 (95% CI, 1.04–7.88); P = 0.042]. Rates of successful reperfusion, overall mortality at 90 days, and SICH were similar between the groups. Multivariate analysis showed that a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (P = 0.005), intraprocedural tirofiban administration (P = 0.012), and internal carotid artery stent implantation (P = 0.040) were associated with a favorable outcome at 90 days.Conclusion: This study found no evidence that prior intravenous thrombolysis affects clinical or imaging outcomes in patients with acute ischemic stroke due to anterior circulation tandem occlusions after endovascular thrombectomy. Bridging therapy may be associated with an increased rate of aSICH. Intraprocedural tirofiban administration, stent implantation, and a lower baseline NIHSS score were associated with favorable outcomes.


  • Open Access

    Retinoic acid-inducible gene-I aggravates neuroinflammation in early brain injury after subarachnoid hemorrhage through mediating brain microvascular endothelial cell pyroptosis

    by Bowen Sun, Yuchen Li, Shuai Lan, Xi-Ao Wang, Yeping Ling, Harshal Sawant, Bohan Zhang, Jinshuo Yang, Jinju Wang, Pei Wu, et al.


  • Open Access

    Reconstructive endovascular treatment of patients with ruptured distal intracranial aneurysms in posterior circulation: a retrospective cohort study

    by Jinshuo Yang, Qiaowei Wu, Kaikun Yuan, Guang Zhang, Chao Xu, Jiaxing Dai, Yiming Du, Bowen Sun, Yujing Zhu, Shuai Lan, et al.

    Background: Cases of ruptured distal intracranial aneurysms (DIAs) in the posterior circulation are rare. Currently, the most commonly used approach in clinical practice to treat this condition is reconstructive endovascular treatment. However, research on endovascular treatment of intracranial posterior circulation ruptured DIAs is currently lacking. This study aimed to analyze the safety and efficacy of reconstructive endovascular treatment for DIAs in the posterior circulation. Methods: A retrospective cohort study was conducted on patients with ruptured distal posterior circulation aneurysms who underwent endovascular reconstructive treatment at The First Affiliated Hospital of Harbin Medical University from September 2014 to August 2023. We collected and analyzed the patients’ characteristics, clinical outcomes, and angiographic follow-up results. Complications were determined and recorded based on the patients’ hospital records and imaging examination results. Clinical information was collected through neurological assessments and follow-up telephone interviews. Follow-up angiographic evaluations using digital subtraction angiography (DSA) were planned for 6 months after the procedure until 1-year postprocedure. Results: The procedure was successfully performed on all 49 patients. Among the patients, 16 (32.7%) were males with a median age of 59.0±12.7 years. A total of 15 (30.6%) patients used stent-assisted coiling. During hospitalization, 16 (32.7%) patients experienced complications, including 6 with hemorrhagic complications, 7 with ischemic complications, and 4 with shunt-dependent hydrocephalus. One patient had both shunt-dependent hydrocephalus and ischemic complications. Three (6.1%) patients died during hospitalization, all related to aneurysm rebleeding. All patients underwent clinical follow-up, with a median follow-up time of 39 months [interquartile range (IQR), 21.0–70.5 months]. At the last follow-up, 42 (85.7%) patients had a modified Rankin scale score of 0–2. During the follow-up period, one patient died, resulting in an overall mortality rate of 8.2% (4/49). A total of 35 surviving patients underwent angiographic follow-up, with a follow-up rate of 76.1% (35/46) and a median follow-up time of 8.5 months (IQR, 6.0–12.0 months). Among the follow-up patients, 94.3% were classified as Raymond-Roy grade 1–2, and two patients experienced residual aneurysm. Survival analysis showed a 1-year complication-free survival rate of 69.4% and a 1-year overall survival rate of 89.3%. Conclusions: This study found that the incidence of complications during hospitalization was relatively high. However, the clinical follow-up results were satisfactory, and imaging follow-up demonstrated a high aneurysm occlusion rate. In summary, endovascular treatment of ruptured DIAs in the posterior circulation is feasible, safe, and effective, but attention should still be paid to the occurrence of related complications.


  • BL-918 alleviates oxidative stress in rats after subarachnoid hemorrhage by promoting mitophagy through the ULK1/PINK1/Parkin pathway

    by Jinshuo Yang, Qiaowei Wu, Yuchen Li, Yongzhi Zhang, Shuai Lan, Kaikun Yuan, Jiaxing Dai, Bowen Sun, Yuxiao Meng, Shancai Xu, et al.